Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayne Gilbert

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Pharmaceutics|December 23, 2022
Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer CellsAleen Khoury, Jennette A Sakoff, Jayne Gilbert, et al.
Bioorganic & Medicinal Chemistry|September 18, 2007
Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivityScott G Stewart, Timothy A Hill, Jayne Gilbert, et al.
Frontiers in Chemistry|July 8, 2024
Next-generation of BBQ analogues that selectively target breast cancerJennifer R Baker, Jayne Gilbert, Nicholas S O'Brien, et al.
Journal of Inorganic Biochemistry|November 30, 2025
Potent anticancer 5-fluorouracil platinum(IV) prodrugsAleen Khoury, Maria George Elias, Jennette A Sakoff, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2007
Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activityTimothy A Hill, Scott G Stewart, Benjamin Sauer, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2011
Norcantharidin analogues with nematocidal activity in Haemonchus contortusBronwyn E Campbell, Mark Tarleton, Christopher P Gordon, et al.
Bioorganic & Medicinal Chemistry|July 4, 2007
Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluationTimothy A Hill, Scott G Stewart, Stephen P Ackland, et al.
Pharmaceutics|April 23, 2022
Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer ActivityAleen Khoury, Jennette A Sakoff, Jayne Gilbert, et al.
Dalton Transactions (Cambridge, England : 2003)|December 2, 2017
Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analoguesBenjamin J Pages, Jennette Sakoff, Jayne Gilbert, et al.
Organic & Biomolecular Chemistry|January 15, 2013
Synthesis and evaluation of novel ellipticines as potential anti-cancer agentsFiona M Deane, Elaine C O'Sullivan, Anita R Maguire, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Pharmaceutics|December 23, 2022
Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer CellsAleen Khoury, Jennette A Sakoff, Jayne Gilbert, et al.
Bioorganic & Medicinal Chemistry|September 18, 2007
Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivityScott G Stewart, Timothy A Hill, Jayne Gilbert, et al.
Frontiers in Chemistry|July 8, 2024
Next-generation of BBQ analogues that selectively target breast cancerJennifer R Baker, Jayne Gilbert, Nicholas S O'Brien, et al.
Journal of Inorganic Biochemistry|November 30, 2025
Potent anticancer 5-fluorouracil platinum(IV) prodrugsAleen Khoury, Maria George Elias, Jennette A Sakoff, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2007
Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activityTimothy A Hill, Scott G Stewart, Benjamin Sauer, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2011
Norcantharidin analogues with nematocidal activity in Haemonchus contortusBronwyn E Campbell, Mark Tarleton, Christopher P Gordon, et al.
Bioorganic & Medicinal Chemistry|July 4, 2007
Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluationTimothy A Hill, Scott G Stewart, Stephen P Ackland, et al.
Pharmaceutics|April 23, 2022
Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer ActivityAleen Khoury, Jennette A Sakoff, Jayne Gilbert, et al.
Dalton Transactions (Cambridge, England : 2003)|December 2, 2017
Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analoguesBenjamin J Pages, Jennette Sakoff, Jayne Gilbert, et al.
Organic & Biomolecular Chemistry|January 15, 2013
Synthesis and evaluation of novel ellipticines as potential anti-cancer agentsFiona M Deane, Elaine C O'Sullivan, Anita R Maguire, et al.
Pageof 6